The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis
Lixiang Le1, Haojie Shan2, Yiwei Lin2
1Department of Orthopedic Surgery, the Second Affiliated Hospital of Soochow University, China.
Abstract:
Osteomyelitis is the infection and destruction of the bone. To date, there is no universal protocol for its treatment. Receptor-interacting serine/threonine-protein kinase 2 (RIPK2) has been implicated in osteomyelitis development. However, the detailed mechanism remains unknown. Here, 6-8w wild-type or Pellino E3 Ubiquitin Protein Ligase Family Member 3 (Peli3)-deficient mice were injected with Staphylococcus aureus to induce osteomyelitis. RAW264.7 cells or bone marrow-derived macrophages isolated from mice were treated with lipopolysaccharide (LPS). Knocking down Peli3 in RAW264.7 cells increased the expression of inflammatory cytokines (interleukin-1β, interleukin-6, and tumor necrosis factor-α) after LPS stimulation. Inflammation was also activated in S. aureus-induced Peli3-deficient mice. Moreover, S. aureus-infected Peli3-deficient mice also displayed more severe symptoms of osteomyelitis than S. aureus-infected wild-type mice. Moreover, Peli3 targets and degrades RIPK2 through K48-linked ubiquitination, and negatively modulates osteomyelitis by degrading RIPK2. Our data further expands the current understanding of RIPK2 in osteomyelitis, and suggests that RIPK2 might serve as a novel therapeutic target for treating osteomyelitis.
Insights
Pellino E3 Ubiquitin Protein Ligase Family Member 3 (Peli3) deficiency exacerbates osteomyelitis by increasing inflammation. Peli3 degrades Receptor-interacting serine/threonine-protein kinase 2 (RIPK2), suggesting RIPK2 as a therapeutic target for bone infection.
Area of Science:
- Immunology
- Molecular Biology
- Orthopedics
Background:
- Osteomyelitis, a severe bone infection, lacks a universal treatment protocol.
- Receptor-interacting serine/threonine-protein kinase 2 (RIPK2) is implicated in osteomyelitis, but its mechanism is unclear.
- Pellino E3 Ubiquitin Protein Ligase Family Member 3 (Peli3) role in osteomyelitis is not well-defined.
Purpose of the Study:
- To elucidate the role of Peli3 in osteomyelitis pathogenesis.
- To investigate the interaction between Peli3 and RIPK2 in the context of bone infection.
- To explore potential therapeutic targets for osteomyelitis.
Main Methods:
- Induction of osteomyelitis in wild-type and Peli3-deficient mice using Staphylococcus aureus.
- Stimulation of RAW264.7 cells and bone marrow-derived macrophages with lipopolysaccharide (LPS).
- Assessment of inflammatory cytokine expression and osteomyelitis severity.
- Analysis of Peli3-mediated degradation of RIPK2 via ubiquitination.
Main Results:
- Peli3 knockdown in macrophages increased inflammatory cytokine expression (IL-1β, IL-6, TNF-α) upon LPS stimulation.
- Peli3-deficient mice exhibited heightened inflammation and more severe osteomyelitis symptoms after S. aureus infection.
- Peli3 was found to target and degrade RIPK2 through K48-linked ubiquitination.
- Peli3 negatively modulates osteomyelitis by degrading RIPK2.
Conclusions:
- Peli3 plays a protective role in osteomyelitis by degrading RIPK2.
- RIPK2 signaling contributes to osteomyelitis severity.
- Targeting RIPK2 may offer a novel therapeutic strategy for treating osteomyelitis.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response
The JAK-STAT Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Unfolded Protein Response


